Malignant Urinary System Neoplasm — Trials

Malignant Urinary System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

3,853 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 888
Recruiting: 467
Ph III recruiting: 52
Growth YoY: +13.3%
Industry share: 27%
Top sponsor: National Cancer Institute (NCI)
Termination share: 36.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (556)

clinicaltrialsPublishedShowing 1,301–1,350 of 1,506 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00002589	Lymphocyte Therapy in Treating Patients With Kidney Cancer	unknown	Phase 2	90	National Cancer Institute (NCI)NIH	1	Dec 18, 2013	clinicaltrials
NCT00586495	Long-term Extension From RCC Phase II (11515)	completed	Phase 2	95	BayerINDUSTRY	1	Dec 13, 2013	clinicaltrials
NCT00003585